Ozurdex 0.7 MG implants
Ended Awarded
- Contract number
- SPE2DB25FDRBZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,097
Award facts
- Contract value 100% obligated
- $18,096.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $18,096.84 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Ozurdex 0.7 mg implants. The award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA, valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
Ozurdex implants are ophthalmic devices used in the treatment of ocular conditions, and this procurement reflects the DLA's ongoing need to supply specialized pharmaceutical and medical products to Department of Defense healthcare sites. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure contracts for diverse medical products ranging from prescription medications to specialty biologics and medical consumables. The firm's consistent performance under the DLA's pharmaceutical supply program demonstrates its capability to deliver specialized medical products efficiently to military healthcare facilities across the nation.
Quick answers
Who was awarded contract SPE2DB25FDRBZ?
SPE2DB25FDRBZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FDRBZ worth?
The government has obligated $18,097 on SPE2DB25FDRBZ.
Is contract SPE2DB25FDRBZ an order under another contract?
Yes. SPE2DB25FDRBZ is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDRBZ competed?
The extent of competition for SPE2DB25FDRBZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award